What is the cure rate for Axitinib?
Axitinib (Axitinib) is a targeted therapy drug used to treat advanced renal cell carcinoma (RCC). Its main mechanism is to inhibit the vascular endothelial growth factor receptor (VEGFR), thereby blocking the blood supply of the tumor and slowing down tumor growth. However, it should be emphasized that axitinib is not a curative drug for renal cell carcinoma, but a treatment option that can delay disease progression and improve survival rates.
Renal cell carcinoma is generally considered one of the more difficult cancers to treat, especially in its advanced stages. Axitinib has shown certain efficacy in advanced renal cell carcinoma in some clinical trials, and can prolong patients' survival and slow down the progression of the disease. However, it should be noted that curing cancer is a complex process involving multiple factors, including the type, grade, and extent of spread of the tumor.

At present, the treatment of renal cell carcinoma mainly consists of surgical resection, radiotherapy and targeted therapy. However, for advanced patients, the goal of treatment is more to extend the patient's survival and improve the quality of life rather than to completely cure it. Therefore, one needs to be cautious when talking about the cure rate of axitinib, because there is currently no conclusive evidence that the drug can completely cure renal cell carcinoma.
Axitinib has been launched in China and has been included in medical insurance. Patients can purchase it domestically. The price of 5mg*28 tablets is about 5,000 to 6,000 yuan. For specific prices, please consult the local hospital pharmacy. There are original and generic axitinib drugs abroad. The original drug is Pfizer's original drug, and the price is about 6,000 yuan; the generic drugs are mainly Bangladeshi generics and Indian generics. The price of Bangladeshi generics in 5mg*60 tablets is more than 1,000 yuan, and the price of Indian generics is around a few hundred yuan. The ingredients of original drugs and generic drugs are basically the same.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)